Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 277-086-3 | CAS number: 72928-60-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2018-01-03 to 2018-01-31
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Bis and tris and tetra{N-[(2-ethylanilino) or 2,4(or 2,5 or 2,6)-dimethylanilino]-N’-[(2-ethylanilino) or 2,4(or 2,5 or 2,6)-dimethylanilino] methaniminium} [phthalocyanine(bis and tris and tetra)sulfonato-κ4N29,N30,N31,N32]cuprate(II)
- EC Number:
- 946-424-8
- Molecular formula:
- C32H16-τN8Cu(SO3C17H22N3) (where τ = 2.80 to 3.04)
- IUPAC Name:
- Bis and tris and tetra{N-[(2-ethylanilino) or 2,4(or 2,5 or 2,6)-dimethylanilino]-N’-[(2-ethylanilino) or 2,4(or 2,5 or 2,6)-dimethylanilino] methaniminium} [phthalocyanine(bis and tris and tetra)sulfonato-κ4N29,N30,N31,N32]cuprate(II)
- Test material form:
- solid: particulate/powder
1
- Specific details on test material used for the study:
- STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Elevage JANVIER LABS (53940 Le Genest St Isle– France),
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 8 weeks old
- Weight at study initiation: 191- 210 g (mean 201.2 g)
- Fasting period before study: Drinking water (tap-water from public distribution system) and foodstuff (ENVIGO - 2016) were supplied ad libitum. Food was removed on day -1 and then redistributed 4 hours after the test item administration.
- Housing:
* Housed by group of three in solid-bottomed clear polycarbonate cages with a stainless steel mesh lid.
* Each cage contained sawdust bedding which was changed at least 2 times a week
* cages installed in conventional air conditioned animal husbandry.
- Diet (e.g. ad libitum): foodstuff (ENVIGO – 2016), ad libitum
- Water (e.g. ad libitum): tap-water from public distribution system, ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25°C
- Humidity (%): 30-70%
- Air changes (per hr): at least ten times
- Photoperiod (hrs dark / hrs light):
IN-LIFE DATES:
Step 1:
From: 2018-01-03 To: 2018-01-03
Step 2:
From: 2018-01-15 To: 2018-01-30
Step 3:
From: 2018-01-16 To:2018-01-31
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- DMSO
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle:
* First step: 2.0000 g of test item in a 10 mL volumetric flask and filled up with DMSO
* Second and third steps: 0.3006 g and 0.3000 g of test item in two 10 mL volumetric flasks and filled up with DMSO
- Amount of vehicle (if gavage):10mL /kg bw
- Justification for choice of vehicle: Dimethyl sulfoxide (DMSO) was chosen as it produced the most suitable formulation at the requested concentration.
MAXIMUM DOSE VOLUME APPLIED: 10mL /kg bw
- Doses:
- * Step 1: 2000 mg of test item /kg bw
* Step 2 and 3 : 300 mg of test item /kg bw - No. of animals per sex per dose:
- 3 female rats per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
* Observations: performed daily
* Weighing : at day 0 (just before administration of the test item), day 2, day 7 and day 14
- Necropsy of survivors performed: yes. were euthanized with sodium pentobarbital (Dolethal®).
Only those organs likely to be modified in cases of acute toxicity were examined. No organ was removed and preserved in view to microscopic examinations.
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other:
Macroscopic examinations at the end of the study (after euthanisia) with the examination of organs
likely to be modified in cases of acute toxicity (i.e. oesophagus, stomach, the entire digestif tract, spleen, liver, thymus, trachea, lungs, heart, kidneys, urinary bladder, ovaries, uterus, treatment area,adrenals, pancreas).
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- - Step 1: 3 mortalities in animals treated at 2000 mg test item /kg bw (between 1 and 3 hours post dose)
- Step 2 and 3: No mortality in animals treated at 300 mg test item /kg bw - Clinical signs:
- other: At 2000 mg test item /kg bw : - a decrease in spontaneous activity (3/3) - righting reflex (1/3) - muscle tones (1/3) - an increase of muscle tones (1/3) associated with mydriasis (1/3) - eyes partly closed (3/3) - tremors (2/3) - tonic convulsions (1/3
- Other findings:
- - Other observations:
* Step 1: At 2000 mg test item /kg bw :
Macroscopic examination :
- thinning of corpus (3/3),
- blue stomach contents (3/3).
* Steps 2 and 3 : At 300 mg test item /kg bw:
Macroscopic examination :
- red forestomach (1/6).
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 of the test item is higher than 300 mg/kg body weight and lower than 2000 mg/kg by oral route in the rat.
In accordance with the O.E.C.D. Test Guideline No. 423, the LD50 cut-off of the test item may be considered as 500 mg/kg body weight by oral route in the rat.
According to the criteria for classification, packaging and labelling of dangerous substances and preparations in accordance with the Regulation EC No. 1272/2008, the test item has to be classified in category 4.
The signal word “Warning” and hazard statement H302 “Harmful if swallowed” are required. - Executive summary:
The test item was administered to a group of 3 female Sprague Dawley rats at the dose of 2000 mg/kg body weight and then to a group of 6 female Sprague Dawley rats at the dose of 300 mg/kg body weight.
The experimental protocol was established according to O.E.C.D. Test Guideline No. 423 dated 17 December 2001 concerning acute oral toxicity and the test method B.1tris of Council regulation No.440/2008 dated 30 May 2008.
Three mortalities were noted in animals treated at the dose of 2000 mg/kg body weight between 1 and 3 hours post-dose.
The mortalities were preceded by a decrease in spontaneous activity (3/3), righting reflex (1/3), a decrease of muscle tones (2/3), an increase of muscle tones (1/3) associated with mydriasis (1/3), eyes partly closed (3/3), tremors (2/3) and tonic convulsions (1/3).
The macroscopic examination of the animals revealed a thinning of corpus (3/3), and blue stomach contents (3/3).
No mortality was noted in animals treated at the dose of 300 mg/kg body weight.
No clinical signs related to the administration of the test item were observed during the study.
The body weight evolution of the animals treated at the dose of 300 mg/kg body weight remained normal during the study.
The macroscopic examination of the animals at the end of the study revealed a red forestomach (1/6).
In conclusion, the LD50 of the test item is higher than 300 mg/kg body weight and lower than 2000 mg/kg by oral route in the rat.
In accordance with the O.E.C.D. Test Guideline No. 423, the LD50 cut-off of the test item may be considered as 500 mg/kg body weight by oral route in the rat.
According to the criteria for classification, packaging and labelling of dangerous substances and preparations in accordance with the Regulation EC No. 1272/2008, the test item has to be classified in category 4. The signal word “Warning” and hazard statement H302 “Harmful if swallowed” are required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.